Measurement of Tralokinumab Concentrations in Serum and Tear Fluid of Atopic Dermatitis Patients and the Relationship With Treatment Response and Ocular Surface Disease
Paediatrics
Measurement of Tralokinumab Concentrations in Serum and Tear Fluid of Atopic Dermatitis Patients and the Relationship With Treatment Response and Ocular Surface Disease
Paediatrics

Measurement of Tralokinumab Concentrations in Serum and Tear Fluid of Atopic Dermatitis Patients and the Relationship With Treatment Response and Ocular Surface Disease

Clin Exp Allergy. 2025 Jun 26. doi: 10.1111/cea.70098. Online ahead of print.

NO ABSTRACT

PMID:40571968 | DOI:10.1111/cea.70098